120 related articles for article (PubMed ID: 8179342)
1. Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis.
Paquet P; Nikkels A; Arrese JE; Vanderkelen A; Piérard GE
Arch Dermatol; 1994 May; 130(5):605-8. PubMed ID: 8179342
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced toxic epidermal necrolysis and pancytopenia: a puzzling association.
Paquet P; Jacob E; Pirson J; Pierard GE
Int J Mol Med; 2005 Jul; 16(1):29-33. PubMed ID: 15942674
[TBL] [Abstract][Full Text] [Related]
3. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine.
Friedmann PS; Strickland I; Pirmohamed M; Park BK
Arch Dermatol; 1994 May; 130(5):598-604. PubMed ID: 8179341
[TBL] [Abstract][Full Text] [Related]
4. Analytical quantification of the inflammatory cell infiltrate and CD95R expression during treatment of drug-induced toxic epidermal necrolysis.
Paquet P; Jacob E; Damas P; Pirson J; Piérard G
Arch Dermatol Res; 2005 Dec; 297(6):266-73. PubMed ID: 16249890
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte subsets and Langerhans' cells in toxic epidermal necrolysis. Report of a case.
Merot Y; Gravallese E; Guillén FJ; Murphy GF
Arch Dermatol; 1986 Apr; 122(4):455-8. PubMed ID: 2937370
[TBL] [Abstract][Full Text] [Related]
6. T-cell subsets in drug-induced toxic epidermal necrolysis. Possible pathogenic mechanism induced by CD8-positive T cells.
Miyauchi H; Hosokawa H; Akaeda T; Iba H; Asada Y
Arch Dermatol; 1991 Jun; 127(6):851-5. PubMed ID: 2036032
[TBL] [Abstract][Full Text] [Related]
7. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement.
Correia O; Delgado L; Ramos JP; Resende C; Torrinha JA
Arch Dermatol; 1993 Apr; 129(4):466-8. PubMed ID: 8466217
[TBL] [Abstract][Full Text] [Related]
9. Immunoregulatory effector cells in drug-induced toxic epidermal necrolysis.
Paquet P; Paquet F; Al Saleh W; Reper P; Vanderkelen A; Piérard GE
Am J Dermatopathol; 2000 Oct; 22(5):413-7. PubMed ID: 11048976
[TBL] [Abstract][Full Text] [Related]
10. Impaired antigen presentation in toxic epidermal necrolysis.
Bagot M; Charue D; Heslan M; Wechsler J; Roujeau JC; Revuz J
Arch Dermatol; 1993 Jun; 129(6):721-7. PubMed ID: 8507074
[TBL] [Abstract][Full Text] [Related]
11. Differential pathomechanisms of epidermal necrolytic blistering diseases.
Paquet P; Piérard GE
Int J Mol Med; 2002 Dec; 10(6):695-9. PubMed ID: 12429994
[TBL] [Abstract][Full Text] [Related]
12. Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment.
Hunger RE; Hunziker T; Buettiker U; Braathen LR; Yawalkar N
J Allergy Clin Immunol; 2005 Oct; 116(4):923-4. PubMed ID: 16210071
[No Abstract] [Full Text] [Related]
13. Severe cutaneous adverse reactions to drugs.
Chia FL; Leong KP
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
[TBL] [Abstract][Full Text] [Related]
14. [Toxic epidermal necrolysis].
Krantz T; Agner T; Faber M; Hannibal J; Engquist A
Ugeskr Laeger; 1993 Apr; 155(15):1139-40. PubMed ID: 8488602
[TBL] [Abstract][Full Text] [Related]
15. Toxic epidermal necrolysis: current evidence, practical management and future directions.
Chave TA; Mortimer NJ; Sladden MJ; Hall AP; Hutchinson PE
Br J Dermatol; 2005 Aug; 153(2):241-53. PubMed ID: 16086734
[TBL] [Abstract][Full Text] [Related]
16. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
[TBL] [Abstract][Full Text] [Related]
17. In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption.
Mizukawa Y; Yamazaki Y; Shiohara T
Br J Dermatol; 2008 Jun; 158(6):1230-8. PubMed ID: 18363767
[TBL] [Abstract][Full Text] [Related]
18. Toxic epidermal necrolysis successfully treated with etanercept.
Gubinelli E; Canzona F; Tonanzi T; Raskovic D; Didona B
J Dermatol; 2009 Mar; 36(3):150-3. PubMed ID: 19335689
[TBL] [Abstract][Full Text] [Related]
19. Immunological mechanisms of epidermal damage in toxic epidermal necrolysis.
Tohyama M; Hashimoto K
Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):376-82. PubMed ID: 22688730
[TBL] [Abstract][Full Text] [Related]
20. [Epidermic necrolysis: advances in pathogenesis].
Roujeau JC
Ann Dermatol Venereol; 2000 May; 127(5):546-7. PubMed ID: 10863193
[No Abstract] [Full Text] [Related]
[Next] [New Search]
